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Abstract Regulation of basal and induced levels of hsp70 is
critical for cellular homeostasis. Ataxin-3 is a deubiquitinase
with several cellular functions including transcriptional regu-
lation and maintenance of protein homeostasis. While inves-
tigating potential roles of ataxin-3 in response to cellular
stress, it appeared that ataxin-3 regulated hsp70. Basal levels
of hsp70 were lower in ataxin-3 knockout (KO) mouse brain
from 2 to 63 weeks of age and hsp70 was also lower in
fibroblasts from ataxin-3 KO mice. Transfecting KO cells
with ataxin-3 rescued basal levels of hsp70 protein. Western
blots of representative chaperones including hsp110, hsp90,
hsp70, hsc70, hsp60, hsp40/hdj2, and hsp25 indicated that
only hsp70 was appreciably altered in KO fibroblasts and KO
mouse brain. Turnover of hsp70 protein was similar in wild-
type (WT) and KO cells; however, basal hsp70 promoter
reporter activity was decreased in ataxin-3 KO cells.
Transfecting ataxin-3 restored hsp70 basal promoter activity
in KO fibroblasts to levels of promoter activity in WT cells;
however, mutations that inactivated deubiquitinase activity or
the ubiquitin interacting motifs did not restore full activity to
hsp70 basal promoter activity. Hsp70 protein and promoter
activity were higher in WT compared to KO cells exposed to
heat shock and azetidine-2-carboxylic acid, but WT and KO
cells had similar levels in response to cadmium. Heat shock
factor-1 had decreased levels and increased turnover in ataxin-
3 KO fibroblasts. Data in this study are consistent with ataxin-
3 regulating basal level of hsp70 as well as modulating hsp70
in response to a subset of cellular stresses.
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Introduction
Hsp701 is a key protein in cellular homeostasis and
increases rapidly from a low basal level to high levels in
response to a variety of stresses. In response to cellular
stress, heat shock factor 1 (Hsf1) is activated and initiates
a sequence of events including robust activation of the
hsp70 promoter. The increased level of hsp70 protein pro-
tects stressed cells by binding and processing unfolded,
misfolded, and aberrant proteins (Lindquist and Craig
1988; Parsell and Linquist 1993; Hartl et al. 1994;
Voellmy 1994; Wu 1995; Morimoto 1998).
Under normal conditions, most cells and tissues have low
levels of hsp70. Maintaining the basal level of hsp70 is
important for normal cellular functions (Feder et al. 1992;
Volloch and Sherman 1999; Hartl and Hayer-Hartl 2002).
Basal hsp70 appears to regulate several critical cellular
functions including protein folding and transport (Hartl et
al. 1994; Hartl and Hayer-Hartl 2002), helping maintain
Hsf1 in an inactive state (Abravaya et al. 1992; Mosser et
al. 1993; Rabindran et al. 1994; Morimoto 1998), regulating
1 Hsp70 refers to both human and mouse orthologous genes (HSPA1A
and Hspa1a) and proteins (HSPA1A and hspa1a, b)
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apoptosis (Beere and Green 2001), and cell proliferation
(Milarski and Morimoto 1986; Milarski et al. 1989; Taira
et al. 1999). Basal hsp70 has several critical functions;
however, only a few proteins have been identified that
regulate basal levels of hsp70.
Ataxin-3 (Atxn3) is a deubiquitinase (DUB; Burnett et al.
2003; Scheel et al. 2003) present in both plants and animals
and expressed in all or most tissues in humans and mice.
Expansion of a polyglutamine tract in Atxn3 results in the
fatal neurodegenerative disease, spinocerebellar ataxia type 3
(SCA3; also known as Machado–Joseph disease (MJD);
Kawaguchi et al. 1994). SCA3/MJD is a protein conforma-
tional disease (proteinopathy) along with many other neuro-
degenerative diseases including nine polyglutamine diseases,
Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral
sclerosis, prion diseases, and additional diseases that are de-
fined by accumulation of misfolded proteins and/or accumu-
lation of proteins with altered conformations (Carrell and
Lomas 1997; Bucciantini et al. 2002; Walsh et al. 2002;
Sanchez et al. 2003). While pathogenic Atxn3 is responsible
for the protein conformational disease, SCA3/MJD, normal
wild-type Atxn3 has multiple cellular functions, including
helping maintain protein homeostasis (Matos et al. 2011).
Processes regulated by Atxn3 in protein homeostasis include
editing ubiquitinated proteins (Burnett et al. 2003; Schmitt et
al. 2007; Winborn et al. 2008; Todi et al. 2009; Kuhlbrodt et
al. 2011), sequestering aggregated proteins in aggresomes
(Burnett and Pittman 2005; Ouyang et al. 2012), modulating
E3 ubiquitin ligases (Durcan et al. 2010; Scaglione et al.
2011), protein degradation (Burnett et al. 2003; Doss-Pepe et
al. 2003; Zhong and Pittman 2006; Wang et al. 2006; Schmitt
et al. 2007), and stress response (Reina et al. 2010; Araujo et
al. 2011; Rodrigues et al. 2011).
Recent work in our lab demonstrated that Atxn3
responded to select proteotoxic stresses by altering its inter-
actions with two shuttle proteins that function in protein
degradation, valosin-containing protein (VCP/p97) and hu-
man Rad23 (HR23B); furthermore, in response to heat
shock and oxidative stress Atxn3 translocated to the nucleus
(Reina et al. 2010). In follow up experiments, characterizing
Atxn3 functions in response to cellular stress, we observed
that basal levels of hsp70 appeared to be lower in Atxn3 KO
cells. Hsp70 regulation and its functions are critical for
cellular homeostasis; therefore, we examined the possibility
that Atxn3 modulates hsp70.
Materials and methods
Cell culture and treatments
Primary fibroblasts were isolated from postnatal day 4 WT
and Atxn3 KO mouse skin. Several independent primary
fibroblasts cultures were maintained continuously and sub-
cultured as needed until cells emerged that had strong pro-
liferation properties. Lines of WT and KO fibroblasts were
established by multiple subcultures.
WT and KO fibroblasts were exposed to stressors that
induce hsp70 including heat shock, cadmium, and azetidine-
2-carboxylic acid (AZE), as well as 2-deoxyglucose (2-DG),
a stressor that does not routinely induce hsp70. Preliminary
studies identified concentrations and times that minimized
toxicity and resulted in appreciable hsp70 promoter activa-
tion (or >80 % decrease in ATP in the case of 2-DG).
Conditions used for stressors in the study were the follow-
ing: (1) tissue culture dishes were “sealed” with parafilm
and heat shocked at 42 °C in a water bath for 30 or 45 min;
times were restricted to a maximum of 45 min due to heat-
induced misfolding of firefly luciferase and Renilla lucifer-
ase (Harrison et al. 2006); (2) cadmium chloride at 50 uM
for 2–5 h; (3) AZE at 2.5 mM for 6–18 h; and (4) 2-DG at
10 mM for 1–3 h. WT and KO fibroblasts were also treated
with 10 uM cycloheximide (Sigma) 0–8 h to determine
turnover of hsp70 and Hsf1 and treated with 5 uM of the
irreversible proteasome inhibitor, clasto-lactacystin-β-lac-
tone (Biomol), for 1–4 h to follow accumulation of Hsf1.
Cell sorting
Atxn3 KO fibroblasts (600,000 cells/100 mm dish) were
plated and transfected 24 h later with Lipofectamine 2000
(60 ul; Invitrogen) and 24 ug of either GFP or GFP-
Atxn3Q22. After 24 h of transfection, cells were removed
from dishes with trypsin/EDTA, triturated in DMEM con-
taining 10 % serum, counted, pelleted in a centrifuge, and
pellets suspended at a concentration of 5×106/ml in
Dulbecco’s phosphate-buffered saline (PBS; without mag-
nesium chloride or calcium chloride)+2 % BSA and 25 mM
HEPES, pH 7.55. Each cell sorting experiment consisted of
GFP transfected cells and GFP-Atxn3 transfected cells;
presorting processing was staggered to decrease cell aggre-
gation. Just prior to sorting cells, they were passed through a
35 um mesh to decrease aggregates. Cells were sorted using
a FACSVantage SE cell sorter and FACSDiVa software by
the staff in the Flow Cytometry and Cell Sorting Facility
(University of Pennsylvania). Immediately following the
sort, cells were pelleted and frozen at −80 °C until used
for western blots.
Western blots and antibodies
Cultured fibroblasts were rinsed with PBS, scraped from
dishes in PBS, pelleted in a centrifuge, and processed for
western blots or stored at −80 °C. Cell pellets were solubi-
lized in 1 % Triton X-100 in PBS and sonicated with twelve
1-s pulses at level 3.5 (Sonic Dismembrator 60, Fisher
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Scientific). An aliquot was removed for a protein assay and
4× sodium dodecyl sulfate (SDS) sample buffer added to the
remaining sample to generate a final lysate of 1× SDS
sample buffer. Whole mouse brains were removed and
placed in 5 ml of ice-cold PBS and disrupted using a
Polytron (Brinkmann Instruments) on setting 5 for 15 s.
Lysate was removed (1.6 mls) and NP40 added to make a
final concentration of 0.1 %. The sample was triturated for
20 s, sonicated with twenty 1-s pulses at level 5.5 and
centrifuged at 20,000×g for 20 min. An aliquot was re-
moved for protein assay and 4× SDS sample buffer added
to the remaining lysate to generate a final lysate of 1× SDS
sample buffer. Samples were 70 ug protein for cell lysates
and 100 ug protein for brain tissue lysates unless indicated
otherwise.
Following electrophoresis, gels were transferred to PVDF
membranes and blots incubated with the following antibod-
ies at the indicated concentrations: Ataxin-3 1 H9 (1:20,000;
Millipore MAB5360), glyceraldehyde 3-phosphate dehy-
drogenase (GAPDH; 1:40,000; Enzo CSA-335), HSC-70
(1:2,500; Enzo SPA-815), HSP-25 (1:1,000; Enzo SPA-
801), HSP-40 Hdj2 (1:1,000; Enzo SPA-405), HSP-60
(1:3,500; GeneTex GTX110089), HSP-70 (1:2,000; Enzo
SPA-810), HSP-90 (1:1,000; Enzo SPA-846), HSP-110
(1:1,000; Enzo SPA-1101), Hsf1 (1:1,000; Enzo SPA-950).
Western blots were processed with antibodies and then
treated with Western Lighting®Plus-ECL (PerkinElmer)
chemiluminescence reagent and exposed to HyperFilm™
ECL (Amersham). In many cases, western blots were
stripped using Restore™ stripping buffer (Thermo Scientific)
and then reprobed with other antibodies.
For quantitation of western blots, films were scanned at a
resolution of 600 dpi. The area of interest was cropped and
saved as a TIFF file and analyzed with ImageJ software.
Individual boxes were created in ImageJ to encompass each
band; the density of each band and background was quan-
titated and the background subtracted. For most statistical
comparisons, the quantitated bands were normalized to
GAPDH from the same sample and lane (blots were
reprobed with GAPDH so that each lane and band could
be normalized). A two-tailed student’s t test was used to
determine significance.
Hsp70 ELISA assay
Whole brains were removed from WT and Atxn3 KO mice
aged 2, 4, 6, 26, or 63 weeks old. Brains were split along the
median to generate two samples. Half brains were snap-frozen
in liquid nitrogen, weighed (range, 150–250 mg/half brain)
and stored at −80 °C. Frozen brain samples were thawed on
ice and 150 μl of 10 mM Tris buffer added. Samples were
homogenized with a tissue homogenizer (Omni International,
TH2000) for 15 s followed by adding 50 μl of 5× extraction
buffer from the Hsp70 EIA Kit (Enzo Life Sciences, EDKS-
700B). Following a 30-min incubation on ice, samples were
sonicated with 12 pulses on level 7 (Sonic Dismembrator 60,
Fisher Scientific) and then centrifuged at 20,000×g for 5 min.
The supernatant was diluted 1:5 in sample dilutent 2 (compo-
nent in Hsp70 EIA Kit); 100 ul duplicates were used in the
enzyme-linked immunosorbent assay (ELISA) assay and the
remaining supernatant was used for a protein assay and excess
supernatant was stored at −80 °C. Each 96-well ELISA plate
(Hsp70 EIA Kit) contained duplicates of brain samples (1–
2 mg protein), control lysate (2.5 mg protein), and hsp70
standards (1.25, 0.625, 0.313, 0.156, 0.078, 0.039, 0.02, and
0 ng). Control lysate was a mixture of multiple different
lysates; aliquots of control lysate were frozen at −80 °C and
used to normalize brain samples in each experiment. The
protocol provided with the Hsp70 EIA Kit was followed
without modifications for quantification of Hsp70 protein
levels. A Multiskan Plus (Thermo Scientific) was used to
measure absorbance at 450 nm and the data was analyzed
using Ascent for Multiskan andMicrosoft Excel. A two-tailed
student’s t test was used to determine significance.
Luciferase assay
Fibroblasts were plated in 24-well dishes at concentrations
to generate cell densities 24 h later at 40–50 % confluence
(for 48 h transfections) or at 70–80 % confluence (for 24 h
transfections). Cells were transfected using the protocol
provided with Lipofectamine 2000 (Invitrogen) for
NIH3T3 cells. The transfection was optimized with
Lipofectamine 2000 at a ratio of 2:1 to DNA. Total amounts
of DNA were optimized for 24 and 48 h transfections for
expression and low toxicity: (1) 24-h transfections: (a) used
to compare WT and KO cells— 300 ng Hsp70-luc (luc0
firefly luciferase), 10 ng Renilla luciferase (Promega); (b)
used to compare effects of GFP vs GFP-Atxn3 in KO cells
—300 ng Hsp70-luc, 10 ng Renilla luciferase, 300 ng GFP
or GFP-Atxn3; (2) 48-h transfections: (a) used for WT and
KO cells treated with AZE—300 ng Hsp-luc, 10 ng Renilla
luciferase; (b) used to compare effects of GFP vs GFP-
Atxn3 in KO cells treated with AZE–150 ng Hsp-luc, 5 ng
Renilla luciferase, 150 ng GFP, or GFP-Atxn3. Renilla
luciferase was included as an internal control reporter.
After 24–48 h of transfection, firefly and Renilla luci-
ferases were quantitated using the protocol and kit for Dual-
Luciferase Reporter Assay System (Promega) without mod-
ifications. Cells were washed three times with PBS and
lysed in 100 ul passive lysis buffer (Promega); routinely,
20 ul of cell lysate was used for the assay. Both firefly
luciferase activity and Renilla luciferase activity were mea-
sured with a TD20/20 Luminometer (Turner Designs) and
analyzed using Microsoft Excel. The ratio of firefly lucifer-
ase (hsp70 promoter activity) to Renilla luciferase (internal
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control) was determined for each well and triplicates of each
condition were averaged. Each experiment was repeated
three to five times over a period of several weeks to insure
that observations were consistent over time. A two-tailed
student’s t test was used to determine significance.
Knockout mice
Atxn3 knockout mice were generated at Lexicon Genetics
from Omnibank ES cells containing a gene trap insertion in
the Atxn3 gene. The gene trap vector, VICTR48, was inserted
in the first intron downstream of the ATG; the intron sequence
flanking the insertion site (*) is the following: 5′
TCAAGTCATTTGGGTGTTTCTCGGACAA*CCATGTT-
TCATAATCATTTTAGGTTTGG3′. The mice were bred into
a C57Bl/6 background; there is no detectable Atxn3mRNA or
protein in the KO mice.
DNA constructs
GFP-Atxn3 constructs were generated by removing Atxn3-
Q22, Atxn3-Q80, Atxn3Q22C14A, and Atxn3Q22UIM^ (all
three ubiquitin interacting motifs (UIMs) with serine mutated
to alanine) from pFLAG-6A plasmid (provided by Sokol Todi
and Henry Paulson) with HindIII and KpnI and ligated into
the multiple cloning site of pEGFP-C3 (Clontech
Laboratories, Inc). GFP-Atxn3Q22 with UIMs and the cata-
lytic site both mutated was generated by mutating the catalytic
cysteine to alanine in the GFP-Atxn3Q22UIM^ construct
using the QuickChange Site-Directed Mutagenesis kit
(Stratagene). Primers containing the mutation were the fol-
lowing: forward primer, 5′CAA GAA GGC TCA CTT GCT
GCT CAA CAT TGC CTG3′; reverse primer, 5′CAG GCA
ATG TTG AGC AGC AAG TGA GCC TTC TTG3′ (muta-
tions to change cysteine to alanine are underlined). Reactions
and times were performed according to the standard protocol
provided in the QuickChange Site-Directed Mutagenesis kit.
The human hsp70 promoter luciferase reporter used in the
study had 296 base pairs from −259 to +37 relative to the start
site of the human HSPA1A gene (Ray et al. 2004; Fig. 1). The
promoter reporter was used in mouse fibroblasts, so it is
pertinent to provide information and comparison of the simi-
larity of human HSPA1A and mouse Hspa1a for elements
regulating basal- and stress-induced promoter activity (Wu et
al. 1986; Greene et al. 1987; Morgan et al. 1987; Williams et
al. 1989; Williams and Morimoto 1990; Bevilacqua et al.
1997; Christians et al. 1997; Schug and Overton 1997;
Bevilacqua et al. 2000). Nucleotide identity between human
and mouse promoters is 70 %. The 11 transcription elements
depicted in Fig. 1 and associated transcription factors are the
following: two heat shock elements (HSEs; Hsf1/2), three GC
boxes (Sp1), three AP2α elements (AP2α), two CCAAT
boxes (CTF/CBF/CREB binding protein (CBP)), and one
TATA box (TFIID). Of these 11 elements, there are three to
four differences between human and mouse: (1) the mouse
does not have the GC box at −245 and no obvious element at
this position, (2) the mouse replaces the AP2α element at −20
with a GC box, and (3) mouse replaces the CCAAT box at
−152 and AP2α element at −137 with a TRE element (AP1
transcription factor) flanked by GC boxes upstream and
downstream of the TRE element.
Results
The preliminary observation that hsp70 protein appeared to
be lower in Atxn3 KO fibroblasts raised the question: does
Atxn3 modulate hsp70 levels and if so, is it a sufficiently
robust effect to detect in mouse tissue? To investigate this,
we used western blots to examine the level of hsp70 in WT
and Atxn3 KO mouse brain (Fig. 2a). Initial western blots
indicated that hsp70 protein was lower in KO mouse brain.
More extensive experiments using ELISAs to quantitate
hsp70 in WT and KO brains at multiple ages suggested that
Atxn3-regulated basal hsp70 (Fig. 2b). Levels of hsp70
were significantly lower in KO brain in all ages tested
between 2 and 63 weeks (Fig. 2b). By 63 weeks of age, it
appeared that WT and KO levels of hsp70 were converging.
Levels of hsp70 could not be consistently detected with the
ELISA prior to postnatal days 11–12 for KO brain and prior
to postnatal days 7–8 for WT brain (not shown).
Consistent with data from WT and KO mouse brain, the
basal level of hsp70 was decreased in Atxn3 KO fibroblast
lines (Fig. 3a). To determine if Atxn3 could “rescue” basal
level of hsp70 in KO fibroblasts, cells were transfected with
GFP or GFP-Atxn3 and underwent cell sorting to in-
crease the fraction of cells expressing GFP or GFP-
Atxn3. Transfected GFP-Atxn3 increased the low level
of hsp70 in Atxn3 KO cells, while GFP did not alter
levels of hsp70 (Fig. 3b, c). Taken together, data in
Figs. 2 and 3 were consistent with Atxn3 regulating
the basal level of hsp70.
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Fig. 1 Schematic of 296 base pairs of HSP1A1 promoter used in the study to drive luciferase. Numbering is relative to the start site and 11 elements
involved in basal and stress-induced activity are shown as boxes and their transcription factors above the boxes
To determine if Atxn3 regulated other heat shock proteins,
western blots of WT and KO mouse brain and cultured fibro-
blasts were tested for differential expression of representative
heat shock proteins from major families: hsp110, hsp90,
hsp70, hsc70, hsp60, hsp40/hdj2, and hsp25 (Fig. 4a). In many
cases, chaperones had different protein expression levels in
fibroblasts compared to brain; however, no chaperone, other
than hsp70, showed differential expression between WT and
KO cells or brain (Fig. 4a). AlthoughAtxn3may regulate other
chaperones in addition to hsp70, it does not appear that Atxn3
has a general effect on chaperones in fibroblasts or brain.
Levels of many chaperones change during aging (Morimoto
2008; Calderwood et al. 2009; Gupta et al. 2010; Anckar and
Sistonen 2011; Tower 2011); therefore, we examined the pos-
sibility that Atxn3 may modulate levels of chaperones in aging
brain. To do so, western blots were generated using 80-week
WT and KO mouse brains (Fig. 4b). At 80 weeks of age, WT
and KO mouse brain had similar levels of all chaperones,
including hsp70. The similar level of hsp70 in WT and KO
brain at 80 weeks was consistent with the converging levels of
hsp70 in WT and KO brain with increasing age (Fig. 2b).
Data in Figs. 2, 3, and 4 are consistent with Atxn3
regulating the level of hsp70 in mouse brain and cultured
fibroblasts. Atxn3 has multiple cellular functions, including
regulating protein degradation and transcriptional regula-
tion. Initially, we determined if hsp70 turnover was altered
in mouse Atxn3 KO cells. Treatment of WT and KO cells
with 10 uM cycloheximide indicated that turnover of hsp70
was very similar in WT and KO fibroblasts (Fig. 5a, b). We
then investigated the possibility that Atxn3 regulated the
hsp70 promoter. Atxn3 can function as either a repressor
or enhancer (Li et al. 2002; Evert et al. 2006; Araujo et al.
2011). Hsp70 promoter activity was monitored using an
hsp70 promoter-luciferase reporter from the human
HSPA1A gene (Ray et al. 2004; see Fig. 1). Basal hsp70
promoter reporter activity was approximately two times
higher in WT compared to KO cells (control, Fig. 6a).
Transfecting GFP did not alter the level of hsp70 promoter
luciferase (not shown). Transfecting WT and KO cells with
Atxn3 increased promoter activity to similar levels of acti-
vation (Fig. 6a). This resulted in ∼50 % increase in promoter
activity in WT cells and ∼200 % increase in KO cells.
Pathogenic Atxn3Q80 with an expanded tract of 80
Fig. 2 Basal level of hsp70 is decreased in Atxn3 KO brain. aWestern
blot of 6-week-old WT and Atxn3 KO mouse brains. The western blot
was probed for hsp70 and then stripped and probed for Atxn3 and
GAPDH; GAPDH was used as a loading control. b Quantitation of
basal levels of hsp70 in WT and Atxn3 KO mouse brain. A mouse
hsp70 ELISA was used to quantitate hsp70 in whole brain lysate from
mice 2, 4, 6, 26, and 63 weeks of age. Data points represent mean±SD
of three or four WT or KO mice. Hsp70 was significantly lower in KO
brains compared to same age WT brains at all ages tested (P<0.05, 2,
and 63 weeks; P<0.01, 4, 6,and 26 weeks)
Fig. 3 Basal level of hsp70 in cells is regulated by Atxn3. Fibroblast
lines were established from WT and Atxn3 KO mice. aWestern blot of
WT and KO cells. GAPDH was used as a loading control. b Atxn3 KO
cells were transfected with GFP or GFP-Atxn3 and sorted 24 h later to
increase the fraction of transfected cells; control KO cells were not
transfected. The blot was sequentially probed for hsp70, GAPDH,
Atxn3, and GFP. c Quantitation of western blots from cell sorting
experiments. Data represent the mean±SD of three independent experi-
ments (*P<0.05; compared to GFP transfected sorted cells)
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glutamines was equally effective as wild-type Atxn3Q22
increasing basal promoter activity in both WT and KO cells
(Fig. 6a). However, mutations that altered DUB activity or
ability to bind ubiquitin chains were less effective in restor-
ing promoter activity (Fig. 6b). Atxn3 KO fibroblasts were
transfected with hsp70 luciferase reporter, Renilla lucifer-
ase, and wild-type Atxn3 or Atxn3 with mutations that
inhibited DUB activity (Atxn3C14A), or binding ubiquitin
chains (Atxn3UIM^), or mutations for both DUB activity
and binding ubiquitin chains (Atxn3C14AUIM^). All muta-
tions significantly decreased the ability of Atxn3 to “rescue”
basal promoter activity (Fig. 6b). However, Atxn3 with both
DUB activity and ubiquitin chain binding mutated still had
about 50 % increase in promoter activity indicating that
other functions of Atxn3 are involved in modulating basal
hsp70 promoter activity.
To determine if Atxn3 modulation of hsp70 promoter
activity extended beyond basal activity, WT and KO cells
were treated with stressors that induce hsp70 (heat shock,
cadmium, and AZE), as well as a stressor that typically does
not induce hsp70, 2-DG. Following heat shock, there was a
striking increase in hsp70 promoter activity between 30 and
45 min (Fig. 7a), while hsp70 reporter activity increased
between 6 and 18 h in AZE-treated cells (Fig. 7b) and
between 2 and 5 h for cadmium-treated cells (Fig. 7c).
Hsp70 promoter activity was higher in WT cells in response
to heat shock and AZE. This suggested that Atxn3 modu-
lated stress-induced hsp70 promoter activity in response to
these stresses. In contrast, following cadmium stress hsp70
promoter activity had similar activity in WT and KO cells at
5 h (Fig. 7c). As expected, 2-DG had no obvious effect on
hsp70 promoter activity in either WT or KO cells. An
interesting aspect of the data was that at early times hsp70
promoter activity increased more rapidly in KO cells com-
pared to WT cells even with stresses that ultimately had a
more robust induction in WT cells (Fig. 7 a', b, c').
Comparing KO to WT cells as a ratio of hsp70 promoter
induction (KO/WT) showed a more rapid increase early in
KO cells and a more rapid increase later in WT cells: (a) heat
shock: 0–30 min01.8, 30–45 min00.62; (b) AZE: 0–6
h04.04, 6–18 h00.35; (c) cadmium: 0–2 h010.0, 2–4
h02.56, 0–4 h03.54, 4–5 h00.84.
Atxn3 appeared to modulate hsp70 promoter activity in
response to heat shock and AZE stress but not to cadmium
Fig. 4 Expression of chaperones in WT and Atxn3 KO brain and
fibroblasts. a Expression of chaperones in WT and KO fibroblasts
and 6-week WT and KO whole brain. Half brains were combined from
two different WT and two different KO mice to generate lysates. b
Expression of chaperones in 80-week WT and KO whole brain. West-
ern blots in panels a and b were initially probed for hsp70 and then
stripped and probed for other proteins. Each chaperone was tested a
minimum of three times on different blots and paired with different
chaperones on each blot to provide an accurate representation of the
composite blot Fig. 5 Turnover of hsp70 in WT and Atxn3 KO fibroblasts. a Western
blot of WTand KO cells treated with cycloheximide (CHX) for 0, 2, 4, 6,
or 8 h and probed for hsp70. The KO western blot was exposed for a
longer period than the WT blot so that similar bands could be viewed. b
Quantitation of hsp70 probed western blots. Data represent the mean±SD
of three independent experiments (there is no significant difference be-
tween WT and KO)
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stress. To determine if hsp70 protein levels showed similar
changes as hsp70 promoter activity in response to stress,
cells were treated with 42 °C heat (45 min), 2.5 mM AZE
(18 h), 50 uM cadmium (5 h), or 10 mM 2-DG (2 h) and
examined using western blots. Times of exposure to stres-
sors were chosen to coincide with robust promoter activity
(see Fig. 7). Hsp70 protein increased following all stresses
except 2DG (Fig. 8a, b). Both heat- and AZE-treated KO
cells had lower levels of hsp70 compared to WT cells
(Fig. 8a,b); this was consistent with decreased hsp70 pro-
moter activity in KO versus WT cells at the same times
(Fig. 7a, b). Hsp70 protein was very similar in WT and KO
cells following cadmium exposure (Fig. 8a, b) consistent
with similar levels of hsp70 promoter activity after 5 h of
exposure (Fig. 7c).
Data generated using WT and KO fibroblasts were con-
sistent with Atxn3 increasing both hsp70 promoter activity
and hsp70 protein in response to heat shock and AZE stress,
while Atxn3 had little or no effect on cadmium stress
(Figs. 7 and 8). To determine if replacing Atxn3 in KO cells
also showed similar effects of modulating stress-induced
hsp70 promoter activity KO fibroblasts were transfected
with either GFP or GFP-Atxn3. Under basal conditions (0
time), transfected Atxn3 increased basal activity of the
hsp70 promoter as previously shown in Fig. 6. In response
to AZE and heat stress, KO cells transfected with GFP-
Atxn3 had increased hsp70 promoter activity compared to
KO cells transfected with GFP (Fig. 9a, b). In contrast, GFP
and GFP-Atxn3 had similar effects with cadmium stress,
suggesting that Atxn3 was not modulating cadmium-
induced hsp70 promoter activity; this is consistent with data
in Fig. 7c using WTand KO cells. As expected, 2DG-treated
KO cells were very similar to control cells with Atxn3
increasing basal hsp70 promoter activity and a similar in-
crease in hsp70 promoter activity in 2DG-treated cells
(Fig. 9d).
Replacing Atxn3 in KO cells increased hsp70 promoter
activity following heat shock and AZE stress. Based on
known functions of Atxn3, it could have direct effects on
transcription or effects through the ubiquitin–proteasome
pathway by altering key proteins that regulate hsp70 induc-
tion in response to stress. Initial experiments focused on
Hsf1. Hyperphosphorylation associated with activation of
Hsf1 had similar temporal shifts in WT and KO cells in
response to heat shock; however, the level of Hsf1 was
consistently decreased in KO cells under basal conditions
and in response to heat shock stress (Fig. 10). WT and KO
fibroblasts were treated with cycloheximide to determine if
Hsf1 had altered turnover in KO cells. Turnover of Hsf1 was
more rapid in KO cells compared to WT cells (Fig. 11a, b).
Treating cells with the proteasome inhibitor, clasto-
lactacystin-β-lactone, increased the level of Hsf1
(Fig. 11c). However, Hsf1 in KO cells accumulated more
rapidly relative to WT cells while GAPDH accumulation
was similar in WT and KO cells (Fig. 11d). This is consis-
tent with the more rapid turnover of Hsf1 in KO cells
(Fig. 11a, b).
Discussion
Hsp70 maintains homeostasis under basal conditions by
regulating multiple processes. These processes include fold-
ing newly translated proteins, binding aberrant proteins to
Fig. 6 Modulation of basal hsp70 promoter activity by Atxn3. a Cells
were transfected with hsp70 promoter-luciferase reporter, Renilla lu-
ciferase, and GFP (control), or GFP-Atxn3Q22, or GFP-Atxn3Q80.
Data represent the mean±SD of three independent experiments with
Hsp70 promoter activity expressed relative to WT control cells (*P<
0.05, relative to WT control). b Effect of Atxn3 mutations on basal
hsp70 promoter activity. KO cells were transfected with hsp70
promoter-luciferase reporter, Renilla luciferase, and GFP (control), or
GFP-Atxn3Q22, or GFP-Atxn3Q22 with mutations that inactivate
DUB activity (Atx3C14A), ubiquitin chain binding (Atx3UIM^), or
inactivate both DUB activity and ubiquitin chain binding (Atx3-
C14AUIM^). Data represent the mean±SD of three independent
experiments with Hsp70 promoter activity expressed relative to control
KO cells transfected with GFP (*P<0.05, **P<0.025; relative to KO
cells transfected with GFP-Atxn3)
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protect cellular proteins from nonproductive or “toxic”
interactions, as well as facilitating their degradation
(Sherman and Goldberg 2001; Hartl and Hayer-Hartl
2002; Bukau et al. 2006). Under stressful conditions,
hsp70 increases rapidly and in concert with protein degra-
dation pathways protect cells from aberrant and misfolded
proteins. Data in the current study are consistent with Atxn3
modulating levels of hsp70 and previous studies are
Fig. 7 Stress-induced hsp70 promoter activity in WT and Atxn3 KO
cells. WT and KO cells were transfected with hsp70 promoter-
luciferase reporter and Renilla luciferase. After 24 h cells were exposed
to: a 42 °C heat shock, b 2.5 mM azetidine-2-carboxylic acid, c 50 uM
cadmium, or d 10 mM 2-deoxyglucose; at the indicated times cells
were lysed and lucifierase activity measured immediately. Panels a′
and c′ are enlarged areas of early time points for a and c. Hsp70
promoter activity is expressed relative to WT control cells (0 time).
Data represent the mean±SD of three or four independent experiments
(*P<0.05; comparison of WT and KO cells responding to stress; all
basal levels and all 2-DG times were significantly different between
WT and KO cells but are not identified with asterisks)
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consistent with Atx3 regulating protein degradation (Zhong
and Pittman 2006; Wang et al. 2006; Schmitt et al. 2007;
Winborn et al. 2008; Durcan et al. 2010; Scaglione et al.
2011) suggesting that Atxn3 helps regulate two key cellular
processes that protect cells against aberrant proteins.
Maintaining the basal level of hsp70 is critical for normal
functions including protein folding (Hartl and Hayer-Hartl
2002), cell proliferation (Milarski and Morimoto 1986;
Feder et al. 1992; Krebs and Feder 1997; Volloch and
Sherman 1999), apoptosis (Vayssier and Polla 1998; Li et
al. 2000; Beere and Green 2001), and potentially helping
maintain Hsf1 in a nonfunctional state in the absence of
stress (Nollen and Morimoto 2002). Basal levels of hsp70
vary depending on type of cell, phenotype, tissue, or indi-
vidual humans (Greene et al. 1987; Locke et al. 1991;
Cowley et al. 1995; Muller et al. 1996; Manzerra et al.
1997; D’Souza and Brown 1998; Xiao et al. 2003; O’Neill
and Noble 2004; Noonan et al. 2007; Salway et al. 2011). It
is not clear how the basal level of hsp70 is established and
maintained; however, Atxn3 is a widely expressed protein
and data in this study is consistent with Atxn3 helping
maintain levels of hsp70 in mouse brain and fibroblasts by
modulating hsp70 promoter activity.
The hsp70 promoter has multiple elements that maintain
and modulate the basal level of hsp70 (Fig. 1). Having
multiple basal elements should allow the hsp70 promoter
to respond to variable changes in the local environment
independent of modulation of hsp70 through the stress-
induced pathway. The hsp70 promoter reporter used in this
study consisted of 296 base pairs from −259 to +37 relative
to the start site of the human HSPA1A gene (Ray et al.
2004); this encompasses the area of the hsp70 promoter that
contains basal and stress-induced hsp70 regulatory ele-
ments. It includes proximal and distal HSE for stress-
induced activity as well as nine elements that can contribute
to hsp70 basal activity including three GC boxes, two
CCAAT boxes, three AP2α elements, and a TATA box
(Wu et al. 1986; Greene et al. 1987; Morgan et al. 1987;
Williams et al. 1989; Williams and Morimoto 1990;
Bevilacqua et al. 1997; Christians et al. 1997). The mouse
Hspa1a promoter is similar to the human promoter with
proximal and distal HSEs, four GC boxes, one CCAAT
box, one AP2α element, one AP1 element, and a TATA
box (Bevilacqua et al. 1997; Christians et al. 1997; Schug
and Overton 1997; Bevilacqua et al. 2000).
Atxn3 can bind directly to DNA; however, it is more
common for Atxn3 to interact with transcription factors, co-
repressors, or co-activators and modulate their functions (Li
et al. 2002; Evert et al. 2006; Araujo et al. 2011). The initial
study by Li et al. (2002) showed that Atxn3 interacted with
three major histone acetyltransferases, CBP, p300, and
p300/CBP-associated factor and inhibited their acetyltrans-
ferase activity resulting in repression of model gene pro-
moters. p300 is associated with transcriptional complexes
on many promoters including complexes on the HSE and
CCAAT boxes in the hsp70 promoter (Li et al. 1998; Xu et
al. 2008; Westerheide et al. 2009). In addition to binding and
altering activity of histone acetyltransferases Atxn3 can bind
to DNA and recruit histone deacetylase 3 and nuclear re-
ceptor corepressor, NCoR, to repress transcription of the
Fig. 8 Stress-induced hsp70 in WT and Atxn3 KO cells. a Western
blots of WT and KO cells exposed to no stress (Con), heat shock for
45 min (42 °C), 2.5 mM AZE for 18 h, 50 uM cadmium for 5 h (Cd) or
10 mM 2-DG for 2 h. Long and short exposures of hsp70 are included
to cover the wide range of hsp70 levels. GAPDH is a loading control. b
Quantitation of western blots. Data represent the mean±SD of three
independent experiments (*P<0.05; comparison of WT and KO cells
responding to stress)
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matrix metalloproteinase-2 promoter (MMP2; Evert et al.
2006). Atxn3 UIMs were required to repress MMP2 tran-
scription but Atxn3 catalytic DUB activity was not required.
A recent study showed that in response to oxidative stress
Atxn3 interacted with the transcription factor, FOXO4, and
enhanced activation of manganese superoxide dismutase
(SOD2) (Araujo et al. 2011). Other experiments indicated
that shRNA knockdown of endogenous Atnx3 decreased
basal expression of SOD2. This study showed that
Atxn3 had an important role in responding to oxidative
stress as well as maintaining the basal level of SOD2
(Araujo et al. 2011).
Using tissue and cells from WT and Atxn3 KO mice, we
showed that basal levels of hsp70 protein and hsp70 pro-
moter activity were lower in KO brain and cells (Figs. 2, 3a,
4, and 6a). Replacing Atxn3 in KO cells increased the low
level of hsp70 protein and promoter activity (Figs. 3b, c and
6). Mutating the catalytic DUB function or UIMs in Atxn3
diminished its ability to increase basal hsp70 promoter
activity (Fig. 6b). Loss of Atxn3 decreased the level of
hsp70 protein; however, it did not appear to have apprecia-
ble effects on protein levels of 6 other chaperones tested in
cells or brain (Fig. 4).
Although Atxn3 regulated hsp70 basal promoter activity
and protein, it was unexpected that Atxn3 also modulated
stress-induced hsp70 promoter activity and protein follow-
ing heat shock and AZE stresses. Hsp70 basal promoter
elements modulate HSE; the increased activity from basal
elements is greater than a simple additive effect (Williams
and Morimoto 1990; Imbriano et al. 2001). The working
model for basal promoter elements modulating the stress-
induced promoter is that a subset of protein complexes
assembled on hsp70 basal promoter elements also interact
with proteins in complexes associated with the HSE and
either enhance or decrease HSE transcription. Williams and
Morimoto (1990) showed that basal promoter activity was
important for robust stress-induced HSE promoter activity.
Mutations in GC and CCAAT boxes that decreased basal
activity also decreased stress-induced promoter activity.
Mutations in basal elements that did not affect basal activity
did not alter stress-induced promoter activity (Williams and
Morimoto 1990). Experiments by Imbriano et al. (2001)
were consistent with the CCAAT-box binding transcription
factors, CTF and NF1, modulating both basal and stress-
induced hsp70 activity by binding to the CCAAT box and
interacting with HSF1 bound to HSE.
Basal promoter activity was lower in Atxn3 KO cells and
increased when Atxn3 was replaced (Fig. 6b); however, a
much greater increase in promoter activity occurred when
Atxn3 was replaced in KO cells that were exposed to heat
Fig. 9 Atxn3 modulates stress-
induced hsp70 promoter activi-
ty in Atxn3 KO cells. KO cells
were transfected with hsp70
promoter-luciferase reporter,
Renilla luciferase, and either
GFP or GFP-Atxn3Q22 and
exposed to no stress (0 time), a
42 °C heat shock for 45 min, b
2.5 mM azetidine-2-carboxylic
acid for 18 h, c 50 uM cadmium
for 5 h, or d 10 mM 2-
deoxyglucose for 2 h. Hsp70
promoter activity is expressed
relative to GFP control cells (0
time) and data represent the
mean±SD of three independent
experiments (*P<0.05; com-
parison of WT and KO cells
responding to stress)
Fig. 10 Hsf1 in WT and KO fibroblasts under basal conditions and
heat shock stress. Western blot of WT and KO cells maintained at 37 °
C (Con) or exposed for 30 min at 42 °C and recovered at 37 °C for
0 min (30+0), 60 min (30+60), or 120 min (30+120) and probed for
Hsf1. GAPDH is a loading control
738 C.P. Reina et al.
shock stress (Fig. 9a). Atxn3 increased hsp70 basal promot-
er activity and this may be responsible for some of the
enhanced stress-induced promoter activity; however,
Atxn3 may modulate stress-induced activity through other
mechanisms. Atxn3 binds to p300 and inhibits its acetyl-
transferase activity (Li et al. 2002). p300 is recruited to the
Hsf1 complex assembled on the HSE promoter in response
to heat shock and acetylates Hsf1 (Xu et al. 2008;
Westerheide et al. 2009). Acetylation of Hsf1 decreases its
binding to DNA resulting in decreased promoter activity
(Westerheide et al. 2009; Anckar and Sistonen 2011).
Therefore, Atxn3 may interact with p300 bound to the
HSE transcription complex and inhibit p300 acetyltransfer-
ase activity, resulting in increased Hsf1 stress-induced ac-
tivity. Alternatively, Atxn3 functions in the ubiquitin
proteasome pathway (Zhong and Pittman 2006; Wang et
al. 2006; Schmitt et al. 2007; Durcan et al. 2010;
Scaglione et al. 2011) and data in Figs. 10 and 11 suggest
that Atxn3 increases the level of Hsf1 protein. The lower
level of Hsf1 in KO cells may reflect an increased turnover
of Hsf1 in the absence of Atxn3 (Fig. 11). Altered turnover
and a more rapid accumulation of Hsf1 in KO cells treated
with a proteasome inhibitor are consistent with Atxn3 reg-
ulating Hsf1 protein through the ubiquitin proteasome path-
way (Fig. 11).
Prior to identifying Atxn3 as a DUB, several studies were
consistent with Atxn3 being involved in the ubiquitin protea-
some pathway. Atxn3 had ubiquitin interacting motifs
(Hofmann and Falquet 2001) and interacted with VCP/p97,
HR23B, and proteasomes (Wang et al. 2000; Doss-Pepe et al.
2003). Once Atxn3 was identified as a DUB (Burnett et al.
2003; Scheel et al. 2003), several studies suggested that Atxn3
functions in cellular proteostasis by decreasing degradation of
a model protein in cells (Burnett et al. 2003), regulating
endoplasmic reticulum degradation (Wang et al. 2006;
Zhong and Pittman 2006), and showing that KO Atxn3 mice
had increased levels of ubiquitinated proteins (Schmitt et al.
2007). In addition, Atxn3 protected Drosophila exposed to
aggregated forms of huntingtin, ataxin-1, and Atxn3 but did
not protect against tau toxicity or a dominant negative hsp70
(hsp70K71E; Warrick et al. 2005).
Recent studies indicate that Atxn3 not only functions in
routine maintenance of cellular proteostasis, but also responds
to stressful conditions. Reina et al. (2010) showed that Atxn3
rapidly localized to the nucleus in response to heat shock and
oxidative stress in an Hsf1-independent mechanism and
Atxn3 protected cells from toxic heat shock, but not from
toxic ER stress or proteasome inhibition. A recent study by
Araujo et al. (2011) showed that Atxn3 translocated to the
nucleus in response to oxidative stress and in combination
with the transcription factor, FOXO4, increased promoter
activity and expression of SOD2. Initial observations of
Atxn3 KO in Caenorhabditis elegans did not detect any
obvious effects (Rodrigues et al. 2007); however, more re-
cently, this group determined that Atxn3 regulated the stress
response in C. elegans (Rodrigues et al. 2011). Surprisingly,
Atxn3 KO C. elegans were more resistant to toxic heat stress
and several chaperones including members of the hsp70
Fig. 11 Turnover of Hsf1 in WT and Atxn3 KO fibroblasts. aWestern
blots of WTand KO cells treated with 10 uM cycloheximide (CHX) for
0, 1, 2, 4, 6, or 8 h and probed for Hsf1. Long and short exposures of
Hsf1 are included to cover the wide range of Hsf1 protein. b Quanti-
tation of western blots of CHX-treated cells probed with Hsf1. Data
represent the mean±SD of three independent experiments (*P<0.05;
comparison of WT and KO cells at same time point). cWestern blots of
WT and KO cells treated with 5 uM lactacystin for 0, 1, 2, 3, or 4 h and
probed for Hsf1 or GAPDH. d Data are presented as KO/WT ratios
from western blots of lactocystin-treated cells and probed with Hsf1 or
GAPDH. Data represent the mean±range bars of two independent
experiments
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family were increased. The protective effects were indepen-
dent of Hsf1 but required the DAF-16 pathway; parallel
experiments byKuhlbrodt et al. (2011) showed that the double
knockout of Atxn3 and CDC48/p97 (a protein that shuttles
ubiquitinated proteins to proteasomes) increased lifespan inC.
elegans through the DAF-16 pathway. DAF-16 is a FOXO
family transcription factor that controls longevity, metabolism
and select developmental processes in C. elegans (Lee et al.
2003). Mammalian orthologs of DAF-16 are FOXO1,3, and
4. It is notable that Atxn3 interacts with mammalian FOXO4
and activates basal and stress-induced expression of SOD2
(Araujo et al. 2011); this is opposite in C. elegans where
Atxn3 KO exhibits enhanced transcription of sod-3 through
DAF-16 (Rodrigues et al. 2011). Differences between C.
elegans and mammals in modulating chaperones may be as
simple as Atxn3 functioning as a co-repressor or a co-activator
at different genes; however, regulation and response to stress
in mammals and C. elegans are very likely more complex.
Atxn3 responds to stress, functions in cellular proteostasis,
and modulates hsp70. Hsp70 is a critical protein for cellular
homeostasis; however, is hsp70 an important aspect of Atxn3
functions and response to stress? It is interesting that hsp70
promoter activity and protein were lower in Atxn3 KO cells in
response to heat and AZE stress while cadmium stress had
similar effects in WT and KO cells (Figs. 7, 8, and 9). Early
effectors of stress signaling are different between cadmium
and heat shock/AZE stresses. An increase in misfolded and
aberrant proteins initiate stress responses in cells exposed to
heat shock and AZE (Morimoto 1998) while cadmium ini-
tiates a stress response by releasing ER calcium, generating
reactive oxygen species and activating MAP kinase signaling
pathways (Thevenod 2009). In that Atxn3 has several func-
tions associated with misfolded proteins including ER protein
degradation (Wang et al. 2006; Zhong and Pittman 2006),
protecting against excess misfolded protein by forming aggre-
somes (Burnett and Pittman 2005; Ouyang et al. 2012) and
protecting organisms from misfolded and aggregated protein
(Warrick et al. 2005) indicates that Atxn3 responds to mis-
folded proteins. Therefore, it seems that Atxn3 would most
likely respond to stresses like heat shock and AZE associated
with excess misfolded proteins. In the context of excess mis-
folded proteins, hsp70 may be an important aspect of Atxn3
protective effects (Warrick et al. 1999, 2005). Atxn3 is
expressed widely in plants and animals and present in most
or all tissues in humans and mice. Therefore, Atxn3 may be a
general modulator of basal hsp70 in many species and tissues
as well as being a potential modulator of hsp70 in response to
stresses associated with excess misfolded proteins.
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